These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1990673)

  • 1. Temporary anti-CD-25 treatment results in tolerance development in syngeneically grafted autoimmune diabetic recipients.
    Hahn HJ; Kuttler B; Dunger A; Lucke S; Volk HD; Diamantstein T
    Transplant Proc; 1991 Feb; 23(1 Pt 1):741-2. PubMed ID: 1990673
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of temporary IL-2 receptor MAB therapy on islet allograft in autoimmune diabetes.
    Hahn HJ; Kuttler B; Lucke S; Dunger A; Besch W; Volk HD; Diamankstein T
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2711-3. PubMed ID: 2495678
    [No Abstract]   [Full Text] [Related]  

  • 3. Interleukin 2 receptor-targeted therapy in islet transplantation research.
    Hahn HJ; Kuttler B; Volk HD; Lucke S; Diamantstein T
    Horm Metab Res Suppl; 1990; 25():177-80. PubMed ID: 2088963
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of anti-interleukin-2 receptor antibody treatment on recurrent autoimmune insulitis in the BB rat.
    Woehrle M; Pullmann J; Stuenkel KG; Bretzel RG; Federlin K
    Transplant Proc; 1994 Apr; 26(2):734-5. PubMed ID: 8171631
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful islet transplantation in BB rats without chronic immunosuppression.
    Chabot JA; Lau H; Reemtsma K; Hardy MA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):974-5. PubMed ID: 3152652
    [No Abstract]   [Full Text] [Related]  

  • 6. Temporary anti-CD25/CsA therapy induces a CD4+ T-cell-mediated tolerance in BB/OK rats.
    Kuttler B; Kauert C; Wanka H; Diamantstein T; Hahn HJ
    J Autoimmun; 1996 Jun; 9(3):321-9. PubMed ID: 8816967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance to islet xenografts induced by dual manipulation of antigen presentation and co-stimulation.
    Markees TG; Appel MC; Noelle RJ; Mordes JP; Greiner DL; Rossini AA
    Transplant Proc; 1996 Apr; 28(2):814-5. PubMed ID: 8623413
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta cell destruction of pancreatic islets transplanted into diabetic BB/OK rats may be reflected by increased antibody-mediated anti-islet cytotoxicity.
    Schröder D; Wanka H; Hehmke B; Klöting I; Köhler E; Knospe S; Schmidt S
    Diabetes Res; 1990 Sep; 15(1):27-32. PubMed ID: 2132197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of islet graft destruction in diabetic mice and rats by temporary anti-IL-2 receptor therapy: comparison of different strategies.
    Kuttler B; Mathieu C; Bulfone-Paus S; Bouillon R; Diamantstein T; Hahn HJ
    Transplant Proc; 1998 Dec; 30(8):4140-2. PubMed ID: 9865327
    [No Abstract]   [Full Text] [Related]  

  • 10. Interleukin 2 receptor targeted immunotherapy in the prevention of autoimmune beta-cell destruction as observed in diabetic BB/OK rats grafted with BB/OK rat islets.
    Hahn HJ; Kauert C; Dunger A; Kuttler B; Diamantstein T
    Autoimmunity; 1989; 5(1-2):139-42. PubMed ID: 2519014
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-dose anti-CD3 therapy provides long-term graft survival in a Lewis rat to C57BL/6 xeno-islet transplantation model.
    Jeyarajah DR; Schmeisser FS; Josephson MA; Sohn DG; Thistlethwaite JR
    Transplant Proc; 1994 Apr; 26(2):771-3. PubMed ID: 8171656
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolongation of islet allografts by pretreatment with intrathymic UV-B donor spleen cells.
    Jin MX; Chowdhury NC; James T; Engelstad K; Hardy MA; Oluwole SF
    Transplant Proc; 1993 Feb; 25(1 Pt 1):291. PubMed ID: 8438304
    [No Abstract]   [Full Text] [Related]  

  • 13. Nature of tolerance induction to peripheral (extrathymic) islet allografts.
    Coulombe M; Lafferty KJ; Gill RG
    Transplant Proc; 1994 Apr; 26(2):720-1. PubMed ID: 8171624
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporine treatment of BB rat pancreas transplant recipients: a functional and histologic analysis.
    Bartlett ST; Dugoni WE
    Transplant Proc; 1990 Apr; 22(2):736-8. PubMed ID: 2109393
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of cytokine transcripts in pancreatic islet cell allografts during rejection and tolerance induction.
    Nickerson P; Pacheco-Silva A; O'Connell PJ; Steurer W; Kelley VR; Strom TB
    Transplant Proc; 1993 Feb; 25(1 Pt 2):984-5. PubMed ID: 8442291
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies of host immunomodulation and prevention of pancreatic beta cell destruction.
    Brayman KL; Naji A; Barker CF
    Transplant Proc; 1990 Apr; 22(2):851-2. PubMed ID: 2109418
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of autoimmune but not allogeneic destruction of grafted islets by different therapeutic strategies.
    Kuttler B; Rösing K; Lehmann M; Brock J; Hahn HJ
    J Mol Med (Berl); 1999 Jan; 77(1):226-9. PubMed ID: 9930969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolongation of islet isograft survival in diabetic NOD mice by anti-L3T4 and anti-LYT2 monoclonal antibodies.
    Matsuo S; Mullen Y; Wicker LS; Peterson LB; Nagata M; Tsunoda T; Clare-Salzler M
    Transplant Proc; 1990 Apr; 22(2):880-1. PubMed ID: 2109427
    [No Abstract]   [Full Text] [Related]  

  • 19. Postoperative bone marrow infusions with cyclosporine, silica, and antilymphocyte serum in rat islet allografts.
    Barneo L; Field MJ; Esteban MM
    Transplant Proc; 1990 Apr; 22(2):859-60. PubMed ID: 2158178
    [No Abstract]   [Full Text] [Related]  

  • 20. Injection of bone marrow cells into the thymus to achieve tolerance in an islet xenotransplant (human-to-rat) model.
    Dellagiacoma G; Rossi M; Castagna MT; Radin S; Vecchioni R
    Transplant Proc; 1994 Jun; 26(3):1114-5. PubMed ID: 8029850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.